Browsing Category

43963 posts
Building AI-Ready Enterprises: New Initiatives to Drive AI Deployment at Scale and Strengthen Digital Resilience

Building AI-Ready Enterprises: New Initiatives to Drive AI Deployment at Scale and Strengthen Digital Resilience

Inaugural SME AI Impact Awards and new public-private partnerships to accelerate enterprise AI…

FlashForge and Meshy Partner to Bring AI Image-to-3D Directly Into Consumer Multi-Color Printing

Meshy’s automatic texture-to-filament color mapping, model quality engine, and broadest DCC bridge…
Aiper Builds Expert-Led Backyard Care Community Through New Aiper Pro Club Initiative

Aiper Builds Expert-Led Backyard Care Community Through New Aiper Pro Club Initiative

Delivering valuable insights, practical guidance, and seasonal strategies, the Aiper Pro Club simplifies…
TWOPAGES X Design Contest 2026 Seeks Pattern Designers Ready to Sell Globally

TWOPAGES X Design Contest 2026 Seeks Pattern Designers Ready to Sell Globally

The home décor brand’s second annual design contest closes in June, with…
Two‑day Global Prosperity Summit 2026 concludes successfully

Two‑day Global Prosperity Summit 2026 concludes successfully

Second-day highlights: digital finance, international trade, aerospace development HONG KONG, May 21,…

Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS

CHENGDU, China, May 21, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.…
FlexClip Unveils AI Long to Shorts, Helping Creators Repurpose Long Videos into Viral-Ready Clips

FlexClip Unveils AI Long to Shorts, Helping Creators Repurpose Long Videos into Viral-Ready Clips

HONG KONG, May 21, 2026 /PRNewswire/ — PearlMountain Limited has enhanced the…

Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLL

Head-to-Head Study Highlights Rocbrutinib as the World’s First Fourth-Generation Dual Covalent and…